CorMedix, Inc. (CRMD)

7.92 -0.13 (-1.61%) USD  |  NASDAQ  |  May 07, 16:00
7.95 +0.03 (+0.38%) Pre-Market: 08:28
More

CorMedix Research and Development Expense (Annual) : 19.33M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Pfizer Inc. 10.25B
Altimmune, Inc. 66.32M
Theravance Biopharma, Inc. 35.91M
REGENXBIO, Inc. 212.68M
Janux Therapeutics, Inc. 125.90M